Teva will pay $ 54 million to settle claims it bribed doctors

Israeli "Teva" pharmaceutical company will pay $ 54 million to settle claims that the company bribed doctors to prescribe copaxone drugs for the treatment of multiple sclerosis and acilectic for the treatment of Parkinson's symptoms, Monday reported overseas.
In a lawsuit filed by two company salesmen, Charles Ernestine and blockbuster Senusi, Teva allegedly paid doctors to prescribe prescriptions for the company's prescription drugs, which would increase sales. It was also alleged that the payments were passed as 'consulting fees' to those doctors, who even appeared at scientific conferences and recommended the drugs.
Teva's attorneys filed a summary judgment motion, but this was denied by a district court judge about 11 months ago. The lawsuit is conducted under the "qui tam" mechanism, which allows corruption revelers to sue the government for spending money illegally and to receive a percentage of the funds.
"This arrangement helps ensure that when a physician chooses a prescription drug for his or her patient, that choice will be driven solely by the patient's best interest and not tainted by improper economic considerations," said attorney Eric Young. "The result today is a victory for American taxpayers who are the victims. The ultimate when unscrupulous people and companies cheat the government, often. "